Login / Signup

[Experience of using tocilizumab in patients with COVID-19 from a referral hospital in Peru].

Antonio Morales-AvalosKenneth G Vargas-PonceJose J Idrogo-AlfaroJuan A Salas-LópezFélix K Llanos-Tejada
Published in: Revista peruana de medicina experimental y salud publica (2021)
Keyphrases
  • rheumatoid arthritis
  • primary care
  • juvenile idiopathic arthritis
  • healthcare
  • rheumatoid arthritis patients
  • acute care
  • adverse drug
  • systemic lupus erythematosus